AP-101
Non-Small Cell Lung Cancer (NSCLC) with specific mutations
Key Facts
Indication
Non-Small Cell Lung Cancer (NSCLC) with specific mutations
Phase
Phase 2
Status
Active, recruiting
Company
About Advance Pharmaceutical
Advance Pharmaceutical is dedicated to translating scientific discoveries into transformative medicines for patients with high unmet medical needs. The company's core technology enables the precise targeting of disease pathways, particularly in oncology and genetic disorders. With a robust pipeline of candidates in various stages of development and a strong leadership team, the company is strategically positioned for growth. Its focus on both internal development and strategic partnerships aims to accelerate the delivery of new therapies to market.
View full company profile